Close X
Attorney Spotlight

How does Jessie Zeigler anticipate the intersection of privacy and smart technology will impact the future of litigation? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Primary Care Providers Win Challenge of CMS Interpretation of Enhanced Payment Law

With the help and support of the Tennessee Medical Association, 21 Tennessee physicians of underserved communities joined together and retained Bass, Berry & Sims to file suit against the Centers for Medicare & Medicaid Services to stop improper collection efforts. Our team, led by David King, was successful in halting efforts to recoup TennCare payments that were used legitimately to expand services in communities that needed them. Read more

Tennessee Medical Association & Bass, Berry & Sims

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Healthcare Private Equity Compliance Checklist

The complex and ever-changing healthcare regulatory and enforcement environment, including increased focus on the role of private equity firms in their portfolio companies, make compliance a top priority for private equity firms investing in healthcare companies. The best way to limit your exposure as a private equity firm is to avoid a compliance misstep in the first place. Additionally, an effective and robust compliance program for your portfolio healthcare company makes it much more attractive to potential buyers and helps you avoid an unexpected and costly investigation or valuation hit down the road. Download the Healthcare Private Equity Compliance Checklist to assess whether your portfolio company's compliance program is up-to-date.

Click here to download the checklist.

Presentation Recap: Diligence Considerations and Risk Management in Healthcare M&A

Events

September 20, 2017

Bass, Berry & Sims attorney Angela Humphreys co-presented at a breakfast program, "Diligence Considerations and Risk Management in Healthcare M&A." Fellow panelists included Will FitzSimons, Senior Managing Director at Arthur J. Gallagher & Co.; Lisa T. Nix, CPA, Practice Leader of Transaction Advisory Services at LBMC; and David M. Pontius, Vice President at MTS Health Investors.

The event provided attendees practical advice on how to mitigate risks in healthcare transactions. Key takeaways included:

  • Valuations are at an all-time high. Buyers do not want to pay an A+ price for a B- asset, which makes diligence key.
  • Deals are running longer before exclusivity. It is a very competitive market. 
  • 34% of all private equity transactions in the first half of 2017 have Reps & Warranties insurance. This is gaining traction in the healthcare space. 
  • Don't lose sight of the issues: identify debt-like liabilities early on. 
  • Engage your team early for billing and coding, financial, and legal diligence and consider a phased approach starting with billing and coding to detect any compliance issues at the beginning. 
  • Sell-side diligence before a transaction launches is becoming more common as dealmakers are recognizing the benefits. 
  • Background checks are a key component of due diligence. 
  • Deals rarely go astray as a result of legal issues, it is almost always a matter of valuation, making the front-end due diligence critical in setting up a higher probability for success.

Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.